ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 136 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 2 | -89.5% | 0.00% | – |
Q1 2017 | $1,000 | -99.7% | 19 | -99.8% | 0.00% | -100.0% |
Q4 2016 | $294,000 | +19.0% | 8,783 | -5.5% | 0.00% | 0.0% |
Q3 2016 | $247,000 | -28.4% | 9,290 | -40.7% | 0.00% | 0.0% |
Q2 2016 | $345,000 | -31.1% | 15,655 | -8.2% | 0.00% | -50.0% |
Q1 2016 | $501,000 | -2.1% | 17,053 | +10.1% | 0.00% | 0.0% |
Q4 2015 | $512,000 | +7.1% | 15,491 | +17.2% | 0.00% | 0.0% |
Q3 2015 | $478,000 | 0.0% | 13,221 | +24.5% | 0.00% | 0.0% |
Q2 2015 | $478,000 | +102.5% | 10,622 | +38.0% | 0.00% | +100.0% |
Q1 2015 | $236,000 | – | 7,698 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |